Gaohong Dong

Suggest Changes
Learn More
BACKGROUND & AIMS Robust clinical data evaluating fibrosis progression in hepatitis C virus (HCV) liver transplant patients receiving an mTOR inhibitor vs. calcineurin inhibitor (CNI) are lacking. To(More)